Willingness-to-payNCT01834313
Willingness to Pay for Patient-centred Care
An observational study of Willingness-to-pay and Patient-centredness, run by A.G. Huppelschoten at 1 site in Netherlands.
Trial summary
The purpose of this study is to evaluate the monetary value of patient-centrednes in health care by determining a willingness-to-pay for more patient-centredness care for both patients and health insurers Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Willingness-to-pay, Patient-centredness
- How many people
- 600 participants
- Where
- 1 siteNetherlands
- Study dates
- Nov 2012to Oct 2013
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patient who are under treatment for their fertility problem and underwent at least one treatment in one of 10 Dutch clinics. All healthcare purchasers from the 5 large Dutch health insurer companies
Who may be able to join
- Patients undergoing MAR-treatment (ovulation induction, intra-uterine inseminations, in vitro fertilization, or intra-cytoplasmic sperm injection)
- All healthcare purchasers working at one of the 5 large Dutch health insurer companies.
Who cannot join
- None
Trial locations and contacts
1 site in 1 country.
Netherlands1 site, 1 recruiting
- Recruiting
Radboud University Medical Centre
Nijmegen, Gelderland, 6500 HB
W L Nelen, 0031-24-3617350, w.nelen@obgyn.umcn.nl
About this study
Official title: Identifying Patients' and Healht Insurers' Preferences Regarding Patient-centred Care by Determining Their Willingness-to-pay for Patient-centred Care
The purpose of this study is to evaluate the monetary value of patient-centrednes in health care by determining a willingness-to-pay for more patient-centredness care for both patients and health insurers
Read the detailed description
We perform our study in the area of fertility care, as it is known that infertile patients suffer from a high physical and physiological burden during treatment and could especially benefit from patient-centred care. Moreover, previous studies have clearly identified the concept of patient-centred fertility care and have shown that improvement is needed.
- Conditions
- Willingness-to-pay, Patient-centredness
- Keywords
- Willingness-to-pay, Patient-centredness, Health insurers, Fertility care
What is being measured
The primary outcome is the main question the study is designed to answer.
Willingness-to-pay for patient-centred care
A willingness-to-pay for patient-centred care for both patients and health insurers
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Apr 2013 (estimated)
- Study startNov 2012
- Primary completionAug 2013 (estimated)
- Study completionOct 2013 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Willingness-to-payStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 600 participants (estimated)
Sponsor and investigators
- Lead sponsor
- A.G. Huppelschoten
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, A.G. Huppelschoten, University Medical Center Nijmegen
- Investigators
- J AM Kremer, MD, PhD, Study chair, Radboud University Medical Centre, NijmegenW L Nelen, MD, PhD, Study director, Radboud University Medical Centre, NijmegenE MM Adang, PhD, Study director, Radboud University Medical Centre, NijmegenA G Huppelschoten, MD, Principal investigator, Radboud University Medical Centre, Nijmegen
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01834313
- Sponsor's protocol ID
- DCE
- Status last verified
- Jul 2013
- First submitted
- 12 Apr 2013
- Last updated
- 23 Jul 2013
- Results posted
- No
- Data monitoring committee
- No
Publications
Huppelschoten AG, Verkerk EW, Appleby J, Groenewoud H, Adang EM, Nelen WL, Kremer JA. The monetary value of patient-centred care: results from a discrete choice experiment in Dutch fertility care. Hum Reprod. 2014 Aug;29(8):1712-20. doi: 10.1093/humrep/deu122. Epub 2014 Jun 4.
PubMed 24903199
Study at a glance
From the registry record, last updated by the sponsor on 23 Jul 2013. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Identifying Patients' and Healht Insurers' Preferences Regarding Patient-centred Care by Determining Their Willingness-to-pay for Patient-centred Care
- ClinicalTrials.gov ID
- NCT01834313
- Acronym / sponsor ID
- DCE
- Conditions
- Willingness-to-pay, Patient-centredness
- Keywords
- Willingness-to-pay, Patient-centredness, Health insurers, Fertility care
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 600 participants (estimated)
- Lead sponsor
- A.G. HuppelschotenUniversity, hospital or other
- Study start
- Nov 2012
- Primary completion
- Aug 2013 (estimated)
- Study completion
- Oct 2013 (estimated)
- First posted
- 17 Apr 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to evaluate the monetary value of patient-centrednes in health care by determining a willingness-to-pay for more patient-centredness care for both patients and health insurers
Detailed description
We perform our study in the area of fertility care, as it is known that infertile patients suffer from a high physical and physiological burden during treatment and could especially benefit from patient-centred care. Moreover, previous studies have clearly identified the concept of patient-centred fertility care and have shown that improvement is needed.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patient who are under treatment for their fertility problem and underwent at least one treatment in one of 10 Dutch clinics. All healthcare purchasers from the 5 large Dutch health insurer companies
Key inclusion criteria (2 listed)
- Patients undergoing MAR-treatment (ovulation induction, intra-uterine inseminations, in vitro fertilization, or intra-cytoplasmic sperm injection)
- All healthcare purchasers working at one of the 5 large Dutch health insurer companies.
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Willingness-to-pay for patient-centred care
Time frame: 6 months
A willingness-to-pay for patient-centred care for both patients and health insurers
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jul 2013.
- Derived from this study: PubMed 24903199Huppelschoten AG, Verkerk EW, Appleby J, Groenewoud H, Adang EM, Nelen WL, Kremer JA. The monetary value of patient-centred care: results from a discrete choice experiment in Dutch fertility care. Hum Reprod. 2014 Aug;29(8):1712-20. doi: 10.1093/humrep/deu122. Epub 2014 Jun 4.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
J AM Kremer, MD, PhD study chair
Radboud University Medical Centre, Nijmegen
W L Nelen, MD, PhD study director
Radboud University Medical Centre, Nijmegen
E MM Adang, PhD study director
Radboud University Medical Centre, Nijmegen
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Willingness-to-pay and Patient-centredness, run by A.G. Huppelschoten at 1 site in Netherlands.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 23 Jul 2013. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Willingness-to-pay for patient-centred care (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01834313, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2013.